300 related articles for article (PubMed ID: 10732657)
1. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.
Pearlstein TB; Halbreich U; Batzar ED; Brown CS; Endicott J; Frank E; Freeman EW; Harrison WM; Haskett RF; Stout AL; Yonkers KA
J Clin Psychiatry; 2000 Feb; 61(2):101-9. PubMed ID: 10732657
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Yonkers KA; Halbreich U; Freeman E; Brown C; Endicott J; Frank E; Parry B; Pearlstein T; Severino S; Stout A; Stone A; Harrison W
JAMA; 1997 Sep; 278(12):983-8. PubMed ID: 9307345
[TBL] [Abstract][Full Text] [Related]
3. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
Halbreich U; Smoller JW
J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
[TBL] [Abstract][Full Text] [Related]
4. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
[TBL] [Abstract][Full Text] [Related]
5. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.
Rapaport MH; Endicott J; Clary CM
J Clin Psychiatry; 2002 Jan; 63(1):59-65. PubMed ID: 11838628
[TBL] [Abstract][Full Text] [Related]
6. Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
Kornstein SG; Pearlstein TB; Fayyad R; Farfel GM; Gillespie JA
J Clin Psychiatry; 2006 Oct; 67(10):1624-32. PubMed ID: 17107257
[TBL] [Abstract][Full Text] [Related]
7. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
[TBL] [Abstract][Full Text] [Related]
8. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
9. Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M; Xiao S
Am J Psychiatry; 2004 Feb; 161(2):343-51. PubMed ID: 14754784
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.
Halbreich U; Bergeron R; Yonkers KA; Freeman E; Stout AL; Cohen L
Obstet Gynecol; 2002 Dec; 100(6):1219-29. PubMed ID: 12468166
[TBL] [Abstract][Full Text] [Related]
11. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
Young SA; Hurt PH; Benedek DM; Howard RS
J Clin Psychiatry; 1998 Feb; 59(2):76-80. PubMed ID: 9501889
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.
Pearlstein T; Yonkers KA; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):275-82. PubMed ID: 15780697
[TBL] [Abstract][Full Text] [Related]
13. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
Freeman EW; Rickels K; Sondheimer SJ; Polansky M
Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
[TBL] [Abstract][Full Text] [Related]
14. Predictors of response to sertraline treatment of severe premenstrual syndromes.
Freeman EW; Sondheimer SJ; Polansky M; Garcia-Espagna B
J Clin Psychiatry; 2000 Aug; 61(8):579-84. PubMed ID: 10982201
[TBL] [Abstract][Full Text] [Related]
15. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
[TBL] [Abstract][Full Text] [Related]
16. Treatment of premenstrual dysphoric disorder with the GABA
Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
[TBL] [Abstract][Full Text] [Related]
17. Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.
Yonkers KA; Altemus M; Gilstad-Hayden K; Kornstein SG; Gueorguieva R
J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):320-325. PubMed ID: 37212651
[TBL] [Abstract][Full Text] [Related]
18. [Psychiatric and psychological aspects of premenstrual syndrome].
Limosin F; Ades J
Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
[TBL] [Abstract][Full Text] [Related]
19. [Sertraline in the treatment of premenstrual dysphoric disorder].
Culav-Sumić J; Skocilić Z; Jukić V
Lijec Vjesn; 1999; 121(7-8):234-8. PubMed ID: 10573958
[TBL] [Abstract][Full Text] [Related]
20. [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].
Marais-Thomas H; Chapelle F; de Vaux-Boitouzet V; Bouvet C
Encephale; 2024 Apr; 50(2):211-232. PubMed ID: 37821319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
